We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PSTI market cap is 41.12M. The company's latest EPS is USD -0.6888 and P/E is -8.42.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 87k | 111k | 54k | 105k | 71k |
| Operating Income | -7.1M | -6.54M | -5.38M | -5.21M | -5.53M |
| Net Income | -7.62M | -6.46M | -4.96M | -4.91M | -5.29M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 54k | 23k | 0 | 234k | 287k |
| Operating Income | -35.53M | -29.48M | -50.62M | -41.59M | -27.25M |
| Net Income | -35.31M | -29.15M | -49.87M | -41.24M | -28.32M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 56.24M | 50.8M | 44.54M | 41.56M | 36.39M |
| Total Liabilities | 35.36M | 35.5M | 33.5M | 34.95M | 34.55M |
| Total Equity | 20.88M | 15.3M | 11.04M | 6.62M | 1.85M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.31M | 65.53M | 93.54M | 68.07M | 50.8M |
| Total Liabilities | 9.49M | 9.43M | 36.39M | 35.88M | 35.5M |
| Total Equity | 21.82M | 56.1M | 57.15M | 32.19M | 15.3M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.96M | -22.86M | -5.86M | -9.51M | -13.71M |
| Investing | 5.37M | 9.7M | 5.8M | 9.72M | 15.39M |
| Financing | 8.03M | 8.02M | N/A | N/A | N/A |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.45M | -26.37M | -30.91M | -36.5M | -22.86M |
| Investing | 1.17M | -30.46M | -7.27M | 11.78M | 9.7M |
| Financing | 23.58M | 60.87M | 61.4M | 7.5M | 8.02M |
| Market Cap | 41.12M |
| Price to Earnings Ratio | -8.42 |
| Price to Sales Ratio | 828.57 |
| Price to Cash Ratio | 44.48 |
| Price to Book Ratio | 15.59 |
| Dividend Yield | - |
| Shares Outstanding | 41.12M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.06 (5.71%) |
| Company Name | Pluristem Therapeutics Inc |
| Address |
matam advanced technology park haifa, north 3508409 |
| Website | https://www.pluristem.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
